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A B S T R A C T
Antimicrobial resistance is a worldwide problem that is both pressing and challenging due to the rate at which it
is spreading, and the lack of understanding of the mechanisms that link human, animal and environmental
sources contributing to its proliferation. One knowledge gap that requires immediate attention is the signiﬁcance
of antimicrobial residues and other pharmaceuticals that are being discharged from wastewater treatment plants
(WWTPs) on the dissemination of antimicrobial resistance in the environment. In this work we provide an
approach to develop a harmonized analytical method for 8 classes of antimicrobials and other pharmaceuticals
that can be used for global monitoring in wastewater and receiving waters. Analysis of these trace organic
chemicals in the inﬂuent and eﬄuent wastewater, and in the respective upstream and downstream receiving
waters from diﬀerent countries across the globe is not trivial. Here, we demonstrated that sample preparation
using solid-phase extraction (SPE) not only provides a convenient and cost-eﬀective shipping of samples, but also
adds stability to the analytes during international shipping. It is important that SPE cartridges are maintained at
cold temperature during shipment if the duration is longer than 7 days because a signiﬁcant decrease in re-
coveries were observed after 7 days in the cartridges stored at room temperature, especially for sulfonamides and
tetracyclines. To compensate for sample degradation during shipment, and matrix eﬀects in liquid chromato-
graphy/mass spectrometry, the use of stable isotope labeled compounds should be employed when available and
aﬀordable. The importance of applying a deﬁned tolerance for the ion ratios (Q/q) that have been optimized for
wastewater and surface water is discussed. The tolerance range was set to be the mean Q/q of the analyte
standard at various concentrations± 40% for the inﬂuent, and± 30% for the eﬄuent, upstream, and down-
stream samples; for tetracyclines and quinolones, however, the tolerance range was± 80% in order to minimize
false negative and false positive detection. The optimized procedures were employed to reveal diﬀerences in
antimicrobial and pharmaceutical concentrations in inﬂuent, eﬄuent, and surface water samples from Hong
Kong, India, Philippines, Sweden, Switzerland, and United States. The antimicrobials with the highest con-
centrations in inﬂuent and eﬄuent samples were ciproﬂoxacin (48,103 ng/L, Hong Kong WWTP 1) and clari-
thromycin (5178 ng/L, India WWTP 2), respectively. On the other hand, diclofenac (108,000 ng/L, Sweden
WWTP 2), caﬀeine (67,000 ng/L, India WWTP 1), and acetaminophen (28,000 ng/L, India WWTP 1) were the
highest detected pharmaceuticals in the receiving surface water samples. Hong Kong showed the highest total
antimicrobial concentrations that included macrolides, quinolones, and sulfonamides with concentrations
reaching 60,000 ng/L levels in the inﬂuent. Antidepressants were predominant in Sweden, Switzerland, and the
United States.
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1. Introduction
The World Health Organization's, 2014 report describes anti-
microbial resistance (AMR) as a global threat to the “eﬀective preven-
tion and treatment of an ever-increasing range of infections caused by
bacteria, parasites, viruses and fungi” (World Health Organization,
2014) making death due to minor infections and cuts possible in a post-
antimicrobial world. As the magnitude and frequency of human mi-
gration and movement increase due to globalization, the spread of re-
sistant bacteria and antimicrobial resistance genes (ARGs) also in-
creases (MacPherson et al., 2009) because bacteria and mobile genetic
elements respect no geographic borders. One factor that contributes to
the emergence of antimicrobial resistant bacteria is the presence of
antimicrobials in the environment. Therefore, it is important to know
how these chemicals enter the environment, to understand the path-
ways through which they disseminate, and to obtain knowledge on how
their environmental occurrence may be controlled.
Antimicrobials and other pharmaceuticals are widely used for
human and veterinary purposes (both therapeutic and prophylactic), as
feed additives in ﬁsh aquaculture, and for growth promotion in live-
stock industries. Global antimicrobial use in animals alone for 2010 was
estimated to be 63,000 tons, and is predicted to increase to
100,000 tons in 2030 (Van Boeckel et al., 2015). The large human
consumption of these drugs and their intensive use in agriculture have
resulted in the widespread occurrence of their residues in the en-
vironment. Antimicrobials are released into the environment in dif-
ferent ways, but primarily through the discharge of eﬄuents from
wastewater treatment plants (WWTPs) and water run-oﬀ from manure-
treated agricultural lands.
WWTP eﬄuents have been identiﬁed as one of the major sources of
antimicrobials and other pharmaceuticals in the environment (Arnnok
et al., 2017; Noguera-Oviedo and Aga, 2016; Vikesland et al., 2017). In
one study, samples from a river impacted by WWTP eﬄuent were found
to contain antimicrobials such as sulfamethazine, amoxicillin, roxi-
thromycin, and erythromycin; with sulfamethazine showing the highest
concentration at 25.97 ng/L (Wu et al., 2016). In a separate study, the
concentrations of diﬀerent classes of antimicrobials detected in the
inﬂuent were compared to those in the eﬄuent to assess the eﬃciency
of removal of these drugs. The most abundant antimicrobials were
tetracyclines, ﬂuoroquinolones, and macrolides. It was found that the
amounts of these antimicrobials decreased in the eﬄuent relative to the
inﬂuent; the inﬂuent concentrations ranged from 111.1 ng/L to
30,049 ng/L, while the eﬄuent ranged from 5 ng/L to 2014 ng/L (Tran
et al., 2016).
Veterinary antimicrobials have also been shown to contaminate
agricultural ﬁelds worldwide because animal manure is typically land-
applied to fertilize croplands. Tetracycline, sulfamethazine, nor-
ﬂoxacin, erythromycin, and chloramphenicol have been found to leach
from soil and enter the aquatic environment through surface run-oﬀ,
especially with the occurrence of a heavy rainfall right after manure
application. The introduction of veterinary antimicrobials from land-
applied animal manure causes their accumulation in soil and in
groundwater (Pan and Chu, 2016). As these chemicals come in contact
with bacteria and other microorganisms in soil it is postulated that this
exposure further augments the proliferation and spread of antimicrobial
resistance in the environment (Pruden et al., 2006). Antimicrobials and
ARGs that enter the environment both contribute to the development of
antimicrobial resistance. It has been shown that low concentrations of
antimicrobials detected in the environment can select for resistant
bacteria, which implies that the consistent release of these anti-
microbials from various sources, contribute signiﬁcantly to the emer-
gence and maintenance of resistance in the environment (Gullberg
et al., 2011). On the other hand, ARGs have also been considered as
emerging contaminants since their release into the environment con-
tributes to the spread of resistance due to horizontal gene transfer
(HGT), which allows for the sharing of these genes between pathogens
and nonpathogens, and even gram – positive and gram – negative
bacteria (Kruse and Sørum, 1994; Pruden et al., 2006).
Other non-antimicrobial pharmaceuticals and personal care pro-
ducts (PPCPs) may also contribute to the selection pressures that ac-
celerate the evolution of antimicrobial resistant bacteria in the en-
vironment. For instance, the antidepressant ﬂuoxetine has been
recently shown to induce multiple AMR in Escherichia coli (Jin et al.,
2018). This ﬁnding is notable because antidepressants are ubiquitous in
surface waters, even in widely diluted large lakes, resulting in the
bioaccumulation in ﬁsh (Arnnok et al., 2017). Furthermore, PPCPs can
negatively impact bioﬁlm respiration and growth (Rosi-Marshall et al.,
2013). Improved understanding of the multitude of routes via which the
above mentioned chemicals enter the environment can provide op-
portunities to prevent their spread, by enabling control strategies that
target sources or identiﬁed critical control points (Larsson et al., 2018;
Vikesland et al., 2017). The major sources of antimicrobial residues and
other PPCP contamination are from the low- and middle-income
countries (LMIC), where environmental regulations are poor and was-
tewater treatment facilities are lacking. Unfortunately, data on the oc-
currence of these contaminants from LMIC are very scarce, due to lack
of resources and analytical capabilities (aus der Beek et al., 2016). Due
to the limited knowledge on the environmental concentrations that
might exert selection for resistant bacteria, it is important to conduct
global-scale monitoring of antimicrobials to provide a basis for de-
termining minimal selective concentrations in complex natural en-
vironments. Key to answering these questions are studies that include
methodologies that allow for the accurate and sensitive measurements
of these drug residues, irrespective of sample origin and the complexity
of the matrix, which may vary signiﬁcantly between countries of origin.
Recent studies on antimicrobials in wastewater involve analysis
only of representative compounds for each class. In addition, most
methods developed for these studies were applied to samples origi-
nating from a single location (Kimura et al., 2014; Novo et al., 2013;
Östman et al., 2017; Senta et al., 2013). Analysis of several compounds
from multiple classes of antimicrobials in samples originating from
multiple locations around the world requires a diﬀerent approach be-
cause of the numerous challenges that need to be addressed in sample
collection, preservation, and analysis. First, simultaneous analysis of
multiple compounds from diﬀerent classes of antimicrobials is diﬃcult
because of the wide range of physical and chemical properties of the
analytes that render eﬃcient extraction and separation under one
condition problematic. Second, wastewater and surface water samples
from each country are likely to have unique matrix properties because
of diﬀerences in the types of treatment processes employed and the
varying government regulations on waste disposal. In addition, diﬀer-
ences in antimicrobial consumption and prescription practices between
countries also result in diﬀerent patterns and types of antimicrobial
residues in the environment (Centner, 2016; Wallinga et al., 2015). The
analysis of a wide range of concentrations, diﬀerent types of drug re-
sidues, and varying sample matrix complexity not only aﬀect method
detection limits, but also the chromatographic retention times of the
compounds (Tran et al., 2016). In addition, for consistency of the global
reconnaissance of antimicrobials, it is ideal to ship the samples to one
location for analysis, hence the stability of the compounds during
shipping must be well characterized. Other challenges regarding in-
ternational shipment include high cost, potential breakage of sampling
containers, and signiﬁcant delays in delivery due to custom require-
ments for water samples that may be considered to be a potential
biohazard.
This study aims to identify challenges and provide solutions to the
problems encountered in the analysis of antimicrobials and other PPCPs
in wastewater and surface water samples from diﬀerent countries. The
goal of the study is to develop a single sensitive and robust analytical
method that can analyze several compounds from multiple classes of
antimicrobials, including beta-lactams, ionophores, macrolides, quino-
lones, sulfonamides, antidepressant drugs and other PPCPs. A stability
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study was performed to mimic the shipping conditions of samples when
they are processed using solid-phase extraction (SPE) to preserve the
analytes and minimize international shipping costs. This study also
demonstrates the advantage of using isotopically labeled standards in
overcoming the challenges of a global-scale reconnaissance study to
collect data on antimicrobials and PPCPs in the environment. While
global surveillance for antimicrobial resistance necessarily includes the
monitoring of bacterial species, it is equally important to monitor re-
sidues of antimicrobials and PPCPs on a global scale. The resulting data
from these studies can be used as guidance in environmental risk as-
sessment for establishing regulations on emission limits of active in-
gredients of pharmaceuticals into the environment, and to serve as a
comprehensive reference framework for future studies to understand
the drivers of environmental antibiotic resistance. In this paper, im-
portant considerations in the analysis of antimicrobials and PPCPs are
discussed and practical protocols that can be implemented in an iden-
tical manner in all countries, even those with limited resources, are
presented.
2. Materials and methods
Acetaminophen (ACT), acetaminophen-d4 (d4-ACT), acetyl-sulfa-
methoxazole (ASMX), acetyl-SMX-d4 (d4-ASMX), amoxicillin (AXC),
ampicillin (AMP), azithromycin (AZI), caﬀeine (CAF), carbamazepine
(CBZ), cefapirin (CFP), ceftiofur (CFT), clarithromycin (CLA), deme-
clocycline (DMC, surrogate), dicloxacillin (DCXC), enroﬂoxacin
(ENRO), erythromycin (ERY), ibuprofen (IBU), ibuprofen-d3 (d3-IBU),
iopamidol (IOPA), lasalocid (LAS), maduramycin (MAD), meprobamate
(MEP), metformin (MET), monensin (MON), naproxen (NPX), na-
proxen-d3 (d3-NPX), narasin (NAR), nigericin (NIG), nonactin (NON),
norﬂoxacin (NOR), oxolinic acid (OXO), oxytetracycline (OTC), peni-
cillin G (PENG), penicillin V (PENV), salinomycin (SAL), saraﬂoxacin
(SARA), sulfachloropyridazine (SCP), sulfadiazine (SPD), sulfadi-
methoxine (SDM), sulfamerazine (SMR), sulfameter (SMT), sulfa-
methazine (SMZ), sulfamethizole (SMI), sulfamethoxazole (SMX), sul-
famethoxazole-d4 (d4-SMX), roxithromycin (ROX), tetracycline (TC),
tilmicosin (TIL), trimethoprim (TMP), trimethoprim-d9 (d9-TMP), and
tylosin (TYL) were purchased from Sigma Aldrich. 13C-erythromycin-
H2O (13C-ERY), ciproﬂoxacin (CIP), desvenlafaxine (DES), diclofenac
(DIC), diclofenac-d4 (d4-DIC), and dilantin (DIL) were obtained from
Cambridge Isotopes (Tewksbury, MA). Spiramycin (SPI, mixture of
spiramycin I, II, and III) and sulfathiazole were purchased from ICN
Biomedicals, Inc. (California, USA). Carbamazepine-d10 (d10-CBZ), ci-
proﬂoxacin-d8 (d8-CIP) and caﬀeine-d3 (d3-CAF) were purchased from
CDN Isotopes (Quebec, Canada). Anhydrotetracycline (ATC) chlorte-
tracycline (CTC) was obtained from Acros Organics (New Jersey, USA).
Diphenhydramine HCl (DPH), diphenhydramine-d3 (d3-DPH), bupro-
pion HCl (BUP), bupropion-d9 HCl (d9-BUP), citalopram HBr (CIT),
citalopram-d6 HBr (d6-CIT), paroxetine maleate (PRX), paroxetine-d6
maleate (d6-PRX), venlafaxine (VEN), venlafaxine-d6 (d6-VEN), des-
venlafaxine (DES), desvenlafaxine-d6 (d6-DES), norﬂuoxetine oxalate
(NFLX), norﬂuoxetine-d6 oxalate (d6-NFLX), norsertraline HCl (NSER),
and norsertraline-13C6 HCl (13C6-NSER) were obtained from Cerilliant
(Sigma-Aldrich, St Louis, MO). Barnstead NANOpure™ Diamond
(Waltham, MA) puriﬁcation system was used to obtain 18.2MΩ water
used throughout all experiments. LC-MS grade methanol and acetoni-
trile (Omnisolv™) was obtained from EMD Millipore Corporation
(Billerica, MA). Formic acid (88%) was purchased from Fisher Chemical
(Pittsburgh, PA).
2.1. Sample collection and solid phase extraction (SPE) protocol
2.1.1. Sample pre-treatment
Wastewater samples (0.5 L) were collected in amber glass bottles
pre-rinsed with 10% nitric acid. After acidiﬁcation to pH 2.5 ± 0.5
using 40% phosphoric acid, samples were ﬁltered using 0.45 μm glass
microﬁber ﬁlters to remove particulate matter and microorganisms.
Using a pipette, 2 mL of Na2EDTA (5% w/v in water) was added to each
sample. Subsequently, samples were spiked with surrogate standards
(50 μL of a 1000 μg/L surrogate mixture solution).
2.1.2. SPE procedure
Oasis™ HLB cartridges (500mg, 6mL) were preconditioned with
6mL acetonitrile, followed by 6mL nanopure water. Samples were then
loaded at a rate of 3–5mL/min. Once the sample was completely
loaded, cartridges were allowed to dry for a minimum of 30min.
Samples were wrapped in foil then secured in air-tight plastic bags then
shipped on ice packs to the University at Buﬀalo. Upon receipt, samples
were eluted with 8mL of LC-MS grade acetonitrile. Using a turbo-
evaporator, sample extracts were dried under N2 gas at 35 °C. After
drying, 100 μL of a 1000 μg/L d10-CBZ (as internal standard) was added
to the tubes followed by resuspension of the extracts in 900 μL of
starting mobile phase. Samples were then transferred to 2mL LC-MS
amber vials that were previously desilanized for LC-MS/MS analysis.
2.2. LC-MS/MS analysis
Separation was carried out using an Agilent 1200 LC system (Palo
Alto, CA) with degasser, chiller, quaternary pump, and autosampler.
Two columns were tested for this study: a Waters Cortecs C18+™
column (Milford, Massachusetts) with dimensions 2.1× 150mm and
2.7 μm particle size and a Waters Charged Surface Hybrid (CSH)
column with dimensions 2.1×150mm and 3.5 μm particle size. The
signal-to-noise ratio of individual analyte signals was used to determine
which column is more advantageous for the purposes of this study. The
ﬂow rate was set at 0.2 mL/min. The mobile phase consisted of a gra-
dient program containing mobile phase A (aqueous 0.3% formic acid)
and B (75 methanol/25 acetonitrile, v/v), starting with 90% A and 10%
B that was kept constant for 3min, followed by a linear ramp to 100% B
from 3 to 22min. This condition was kept for 5min, then the mobile
phase was returned back to 10% A within 4min. The column was kept
at this condition for another 14min for column re-equilibration; total
run time is 45min. A Thermo TSQ Quantum Ultra (Waltham,
Massachusetts) triple quadrupole mass spectrometer was used under
positive heated electrospray ionization (+HESI) in timed selected re-
action monitoring (tSRM or EZ method) mode. The details of the SRM
transitions used are shown in Table S1 in the Supporting Information
(SI). Ampicillin, amoxicillin, and cefapirin may degrade faster in the
presence of acid. As an alternative to avoid degradation, the addition of
acid before solid phase extraction can be skipped and the amount of
acid additive in the mobile phase can be changed from 0.3% to 0.01%.
However, this study includes a wide range of chemicals with diﬀerent
physico-chemical properties, and the existing method was found to
work best for most of the compounds.
The mass spectrometer had the following spray settings: spray vol-
tage (3000 V), ion sweep gas pressure (0 arbitrary units), vaporizer
temperature (350 °C), sheath gas pressure (40 arbitrary units, N2),
auxiliary gas pressure (35 arbitrary units, N2), capillary temperature
(325 °C), collision gas pressure (1.5 mTorr, Ar), cycle time (0.300 s),
and Q1 peak width (0.70 FWHM).
2.3. Test of stability in solid phase extraction cartridges
Inﬂuent wastewater samples collected from a local plant (N=21) in
Amherst, NY (USA) were spiked with 50 μL of a 1000 μg/L mixture
containing all target sulfonamides, macrolides, PPCPs, quinolones,
SSRIs, and tetracyclines mentioned above. Samples were prepared and
extracted by SPE; the SPE cartridges were stored either at uncontrolled
room temperature (23–27 °C) or inside a − 4 °C freezer to simulate
“worst” and “best” case scenarios, respectively, during international
shipping. In order to eliminate the possibility of degradation of analytes
due to humidity in the SPE cartridges, the sorbent was dried thoroughly
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under vacuum after loading of the water samples, prior to shipment.
Three samples were eluted and analyzed on the same day of extraction
to serve as the reference condition, during which sample degradation is
unlikely to occur. Then, triplicate SPE cartridges were taken from each
condition after seven, ﬁfteen, and twenty-eight days of storage, for
elution and analysis, to determine recoveries of each of the spiked
analytes. The entire stability study was conducted for a period of four
weeks.
2.4. Eﬀect of matrix on the chromatographic retention times, and
importance of quantiﬁcation by isotope dilution
Aliquots (190 μL) were taken from each type of sample (extracts of
wastewater and surface water) from 6 diﬀerent countries (Hong Kong,
India, Philippines, Sweden, Switzerland, and the United States); a total
of 20 samples were spiked with 10 μL (5% of total volume) of a
1000 ng/L standard mix. These spiked extracts were analyzed using the
optimized LC-MS/MS method to determine whether the diﬀerences in
sample matrix will have a signiﬁcant eﬀect on the chromatographic
retention times of the analytes.
Isotope dilution was used for quantiﬁcation whenever a stable-iso-
tope labeled analogue is available for each target analyte. Known
amounts of labeled analogues were spiked into the water samples prior
to SPE, serving both as surrogate standards to account for recoveries
and as reference standards for quantiﬁcation. For analytes that did not
have a labeled surrogate, structurally similar isotope-labeled internal
standards that have similar physico - chemical properties and retention
times that are suﬃciently close to the target analyte were used for
quantiﬁcation. For the latter method, 380 μL of each unknown sample
was obtained and split into two. The ﬁrst aliquot was spiked with 10 μL
of the standard mix and the second aliquot was spiked with 10 μL of the
starting mobile phase; both of these samples were analyzed by LC-MS/
MS in consecutive runs. The recoveries of the surrogate standards were
monitored in order to account for any degradation of the analytes that
might occur in the SPE cartridges, and to compensate for the diﬀerences
in ionization eﬃciencies resulting from the high variability in the
sample matrices. The ratios of the quantitative ion (Q) over the quali-
tative ion (q) were also monitored, together with the retention time for
quality assurance, as described in our previous publication (Angeles
and Aga, 2018).
3. Results and discussions
3.1. Optimization of chromatographic separation and mass spectrometric
fragmentation
In developing an analytical method for the quantiﬁcation of a
mixture of analytes with a wide range of polarities and acid-base
properties, the ﬁrst critical step is choosing the right chromatographic
column. Between the two LC columns examined, it was found that the
signal-to-noise (S/N) ratio of the analytes were higher using the Waters
Cortecs C18+™ column (Cortecs) with a solid core column and smaller
particle size (2.7 μm) compared to Waters Charged Surface Hybrid
(CSH) with a fully porous particle and a larger particle size (3.5 μm);
these columns have the same dimensions. A summary of the S/N ratios
and the signal improvement observed when using the Cortecs column is
shown in Table 1. The signal improvement was calculated by dividing
the S/N of the peaks obtained with the Cortecs column by the S/N
obtained using the CSH column. Across the board, there is signiﬁcant
improvement in the S/N ratio for all of the compounds studied when
using the Cortecs column. This improvement translates to lower de-
tection limits, which is a critical factor in the trace analysis of anti-
microbials in wastewater. Therefore, subsequent analysis used the
Cortecs column. Diﬀerent separation gradients were also tested, but
only the gradient program that provided the optimum separation of
analytes belonging to the same class of antimicrobials is presented in
this paper.
One of the limiting factors in developing an LC-MS/MS method for
multiple classes of compounds is the number of SRM transitions that
can be incorporated into a single run without losing method sensitivity.
The loss in sensitivity is a consequence of the MS scanning for a ﬁnite
number of mass transitions in a ﬁnite amount of time; a longer dwell
time is preferred for a more accurate measurement. When the MS is set
to scan for a higher number of mass transitions per unit time, the ef-
fective dwell time per mass transition is decreased, which lowers the
number of data points collected per chromatographic peak. This lim-
itation can be circumvented by using the EZ™ method feature of the
instrument software such that only speciﬁc SRM transitions are scanned
for a speciﬁc period of time. By doing so, the number of points collected
per analyte peak is increased, thereby providing a more accurate
measurement, resulting in higher S/N ratios. The ability to create an
EZ™ method provides a means by which a single method can analyze
multiple classes of compounds that would normally be performed in
separate analytical runs, thereby reducing analysis time.
Due to the diﬀerences in matrix complexity that can be expected for
samples coming from diﬀerent countries, it is possible that retention
time shifts in chromatographic separation will occur in an un-
predictable manner. In addition, because diﬀerent countries use dif-
ferent antimicrobials, not all analytes will be present in all samples,
thus making it challenging to determine if the absence of an analyte
peak in the expected chromatographic retention time is truly a negative
detection or due to a retention time shift. Since the positive detection of
a compound in a timed-SRM MS method is highly dependent on the
analyte's retention time, signiﬁcant diﬀerences in matrix that lead to
retention time shifts may cause a false-negative detection of a com-
pound. Therefore, the robustness of the chromatographic method was
tested by spiking aliquots of inﬂuent and eﬄuent wastewater, and
Table 1
Comparison of the signal-to-noise (S/N) ratios for selected analytes using two
diﬀerent columns.
Signal-to-noise ratio (peak area)
Analyte Cortecs C18+ Charged surface
hybrid (CSH)
Percent
improvement
Macrolides
Clarithromycin 1.7E+07 2.7E+06 630
Erythromycin 5.2E+06 8.7E+05 590
Roxithromycin 5.7E+05 8.7E+05 65
Spiramycin 2 6.7E+06 1.4E+06 500
Spiramycin 3 1.0E+07 1.8E+06 560
Tilmicosin 2.9E+06 4.9E+05 590
Tylosin 6.8E+05 1.5E+05 460
Quinolones
Ciproﬂoxacin 1.9E+04 5.7E+03 340
Enroﬂoxacin 8.1E+03 1.9E+03 430
Norﬂoxacin 1.9E+03 4.1E+03 47
Oxolinic acid 6.6E+03 1.2E+03 540
Saraﬂoxacin 1.3E+04 6.9E+03 200
Antidepressants
Bupropion 2.5E+04 4.6E+03 530
Citalopram 6.4E+04 1.6E+04 390
Norﬂuoxetine 6.9E+04 2.0E+04 350
Norsertraline 2.5E+04 1.0E+04 240
Paroxetine 2.9E+04 2.6E+04 110
Venlafaxine 1.3E+04 3.3E+03 400
Sulfonamides
Sulfachloropyridazine 2.1E+06 1.4E+04 15,000
Sulfadiazine 3.7E+04 4.9E+04 76
Sulfadimethoxine 1.6E+07 3.5E+06 440
Sulfamerazine 6.3E+06 1.4E+04 45,000
Sulfamethazine 7.2E+06 1.3E+06 540
Sulfamethizole 9.0E+05 2.1E+05 430
Sulfamethoxazole 2.3E+03 6.9E+02 330
Sulfathiazole 2.5E+04 1.2E+04 210
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surface waters collected from upstream and downstream of the WWTPs,
with a known amount of the standard mix. The volume of the spiked
standard was only 5% of the total volume to prevent signiﬁcant changes
in matrix characteristics due to dilution. The goal of this test was to
assess the eﬀect of the diﬀerent matrices on the analyte retention times
and determine if the matrix eﬀects are signiﬁcant enough to result in
false negatives. The average retention times and standard deviations for
the target analytes are summarized in Table S1. Peak shifts can be as-
sessed by looking at the magnitude of the standard deviations; a low
standard deviation indicates reproducible retention times. No sig-
niﬁcant retention time shifts were observed for all of the analytes; er-
ythromycin exhibited the largest shift (0.7 min), but still within the
time range before and after retention time. A signiﬁcant retention time
shift is when the analyte signal is not observed because of elution
outside the time range set for the mass spectrometer to scan for a
speciﬁc MS/MS transition. Since the method was set to scan for a mass
transition within 1.5min before and after the expected retention time,
false-negative detection was prevented. It is also a reﬂection of the
eﬀectiveness of the SPE procedure in minimizing matrix eﬀects that
could aﬀect chromatography.
3.2. Storage temperature aﬀects analyte recoveries and stability in the SPE
cartridge
The stability of antimicrobials in the SPE cartridges was tested
under two diﬀerent storage conditions, −4 °C and room temperature
(23–27 °C), to simulate “best case” and “worst case” scenarios during
international shipping, respectively. SPE cartridge comparison was not
performed due to continued success with using the cartridge used in
this study compared to other cartridges (Arnnok et al., 2017; Mullen
et al., 2017; Su et al., 2014; Tso et al., 2011). Performing SPE in the
country of sample origin after sample collection was advantageous
based on two grounds: ﬁrst, shipping and handling costs can be mini-
mized since only SPE cartridges would be shipped internationally in-
stead of glassware ﬁlled with liquid samples, and second, breakage and
loss of valuable samples could be avoided. Shipping SPE cartridges
rather than bottles of water samples also prevented issues regarding
sample safety since no biologically active material is being transported.
Courier service companies prohibit the shipment of samples containing
ﬂammable solvents such as methanol and acetonitrile, therefore, ship-
ping of SPE-eluate in vials was not considered.
To study the analyte stability at a “worst-case” scenario during
shipping, the SPE cartridges were stored in a room without temperature
control to mimic conditions where the SPE cartridges may thaw out
during shipment, which could happen due to potential delays in ship-
ment release from government customs. Fig. 1 summarizes the results
obtained for the stability of the diﬀerent analytes, presented based on
compound class. Sulfonamides and tetracyclines showed the highest
degradation compared to the other compound classes irrespective of
storage condition. For sulfonamides stored at room temperature, the
recovery dropped from 54% to 43% then 28% between 8, 15, and
28 days of storage in the SPE cartridge, respectively. When stored at
−4 °C, an improvement in sulfonamide recovery was observed for the
ﬁrst 8 days (74%) after which recovery decreased to 33% and 23%
when eluted from the cartridge after 15 days and 28 days, respectively.
For tetracyclines stored at room temperature, the trend in recovery was
decreasing at 36%, 28%, and 21% recovery for elution at 8, 15, and
28 days, respectively. Cold storage showed improvement in tetracycline
recovery at 58%, 53%, and 37% recovery after 8, 15, and 28 days, re-
spectively. In general, a decreasing trend in analyte recovery can be
observed over time for all compound classes. However, no general-
izations regarding compound class stability can be established since
diﬀerent compounds have diﬀerent stabilities irrespective of compound
class.
To determine whether there is a statistical diﬀerence between the
recoveries of each compound during the diﬀerent extraction dates,
Two-Way ANOVA was performed at a 99% conﬁdence level. Whenever
a statistical diﬀerence between the ﬁrst week and second week is ob-
served, a compound was deemed to have started degradation and is
considered to be stable in the SPE cartridge for one week only.
Similarly, when there is no statistical diﬀerence between the recoveries
after 1 day and 8 days of storage, but there is statistical diﬀerence be-
tween the recoveries after 8 days and 15 days of storage, the analyte
was considered to be stable for at least two weeks in the SPE cartridge.
Compounds that do not have statistically diﬀerent recoveries for all
sampling points were considered stable for more than 28 days. Table 2
presents a classiﬁcation of individual compound stabilities in the SPE
cartridges for the two storage conditions. The compounds are listed in
the ﬁrst column when their recoveries in the 8-day samples were sig-
niﬁcantly diﬀerent from the initial analyte recoveries in day 0 (re-
ference value, set as 100%). A signiﬁcant diﬀerence in recovery sug-
gests that either (1) analyte degradation occurred during storage, (2)
analytes irreversibly bound to the SPE packing material, or (3) inter-
actions between the analytes and co-extracted matrix prevented eﬃ-
cient recovery or detection of the analytes in the ﬁnal LC-MS/MS
analysis. Taking the case of ciproﬂoxacin for instance, there is sig-
niﬁcant diﬀerence in the analyte recoveries between day 0 and day 8 in
both room temperature and cold storage, where a 40% drop in the
recovery was observed. Therefore, ciproﬂoxacin (CIP) was classiﬁed as
a compound with a stability window less than 7 days, and was listed in
the ﬁrst column of Table 2 for both storage conditions. For sulfa-
methizole (STZ), the percent recovery after 7 days was 79 ± 15, which
is not signiﬁcantly diﬀerent from the recovery in day 0, but is sig-
niﬁcantly diﬀerent from the recovery in day 15 (33 ± 1) under the
cold storage condition. In contrast, degradation was observed after
7 days, with a 60% drop in recovery between the day 0 and day 7,
under uncontrolled room temperature conditions. Therefore, STZ is
listed in the second column under cold storage (stable for up to
15 days), but is listed in the ﬁrst column under uncontrolled room
temperature storage (stable only for up to 7 days). Using the same logic,
acetyl-sulfamethoxazole (ASMX) did not show signiﬁcant decrease in its
recovery until after day 15, under both storage conditions. Therefore,
ASMX is listed in the third column and is considered stable for up to
15 days of storage in the SPE cartridge.
Table 2 provides guidance on how long SPE cartridges should be
stored under refrigerated and under uncontrolled room temperature
conditions, and indicates what analytes are most aﬀected during long
storage in the SPE cartridge. It is obvious and not surprising that cold
storage increases the stability of the compounds, showing high re-
coveries of the analytes from the SPE cartridges even after one week of
storage. This guideline is helpful in creating protocols for international
collaborations. By keeping the cartridges cold during shipment, the
integrity of the samples can be maintained. Taken from a diﬀerent
perspective, it also implies how there may be an underestimation of
antimicrobial loading when the SPE cartridges do not get analyzed
within a reasonable time scale (less than 7 days). Ideally, all samples
should be eluted and analyzed by LC-MS/MS within two days after
receipt. The number of analytes that degrade during the ﬁrst 7 days of
storage decrease from 33 compounds to 23 compounds when the car-
tridges are kept cold. The beneﬁt of cold storage disappears when the
cartridges are not eluted within 15 days as 38 compounds degrade
within this time frame whether kept in cold or room temperature sto-
rage. Improved class stability is observed for macrolides and sulfona-
mides.
In actual samples, diﬀerences in the extent of degradation of the
analytes in the SPE cartridges could be accounted for by correcting the
analyte recoveries using the observed recoveries of the isotopically-la-
beled surrogate standards. Since the surrogate standards have the same
physico-chemical properties as the corresponding native analytes, de-
gradation and matrix suppression can be corrected for using the sur-
rogate recovery data. Because the accuracy of quantiﬁcation depends
on the accurate spiking of the surrogates, the personnel performing the
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extraction in the diﬀerent sampling sites across the globe must be well
trained prior to the sampling campaign. This training can be accom-
plished by sharing extraction protocols to the diﬀerent laboratories
together with the preparation of instructional videos and actual hands-
on training, whenever possible.
The ion ratio (Q/q), which is the area of the quantiﬁer ion (Q) di-
vided by the area of the qualiﬁer ion (q), has been used as an additional
criterion for reporting analyte detection (Mol et al., 2015). For this
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Fig. 1. The stability of analytes inside a solid phase extraction (SPE) cartridge diﬀers by compound class. Sulfonamides, SSRIs (antidepressants), and tetracyclines
show faster degradation while macrolides, quinolones, and other pharmaceuticals and personal care products (PPCPs) show longer stability inside the cartridge. SSRI:
selective serotonin reuptake inhibitor.
Table 2
Using two-way ANOVA and a P-value of 0.01, diﬀerences in the stability of individual compounds from day 0 to day 28 were compared. It can be observed that the
stability of the compounds in the cartridge get extended to longer days when the cartridges are kept in−4 °C compared to room temperature. The decrease in number
of analytes that degrade within 7 days is evident with the decrease in the number of analytes that show signiﬁcant diﬀerence in stability; 33 analytes degrade within
the ﬁrst 7 days compared to 23 analytes. Improved class stability is observed for macrolides and sulfonamides.
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study, a tolerance range for Q/q of all target analytes in wastewater and
surface water has been set be equal to the mean Q/q of the analyte
standard± 40% for inﬂuent samples, and mean Q/q ± 30% for the
eﬄuent, upstream, and downstream samples (Angeles and Aga, 2018).
For tetracyclines and quinolones, however, a wider tolerance range was
implemented, using mean Q/q ± 80% to avoid false negatives. How-
ever, for these compounds all positive peaks need to be veriﬁed care-
fully by inspecting the peaks individually before reporting any positive
detections (Angeles and Aga, 2018).
Ciproﬂoxacin was the antimicrobial with the highest levels de-
tected, with a concentration of 48,103 ng/L found in the inﬂuent was-
tewater sample from Hong Kong. This value was validated with the
spiked surrogate and met all the criteria for positive detection. First, the
peak for ciproﬂoxacin came out at the retention time that agrees with
the retention time of the surrogate standard. Second, both quantiﬁer
and qualiﬁer ions are present (Fig. S1). Third, the Q/q was within the
acceptable range of 0.93 to 8.29 (Angeles and Aga, 2018); in the in-
ﬂuent and eﬄuent samples, the Q/q were 2.28 and 2.79, respectively,
which are within the set range.
3.3. Diﬀerent countries show diﬀerences in antimicrobial concentrations
WWTP samples were received from Hong Kong, India, the
Philippines, Sweden, Switzerland, and the United States and included
inﬂuent, eﬄuent, upstream, and downstream samples. Analysis of
samples revealed diﬀerences in the antimicrobial proﬁles, which are
shown in Fig. 2. The contaminant loading is presented as a total of all
the antimicrobials detected, sorted into four compound classes, sulfo-
namides, macrolides, tetracyclines, and quinolones. A diﬀerence in the
concentration scale, due to the higher levels of antimicrobials in the
wastewater compared to surface water, should be noted in the ﬁgures
corresponding to the inﬂuent, eﬄuent, upstream, and downstream
samples. It is also notable that the antimicrobial levels are higher in
samples originating from Hong Kong and India compared to samples
originating from the Philippines, United States, Sweden and Switzer-
land. The inﬂuent from one of the WWTPs sampled in Hong Kong
showed the highest antimicrobial concentrations, which were mainly
quinolones (CIP, NOR) and macrolides (ROX, CLA, AZI), as listed in
Table S2. The second highest concentrations of antimicrobials were
observed in one of the WWTPs in India, which was mainly macrolides
(CLA, AZI, A-ERY). As can be seen in Fig. 2 and Table S2, it can be
deduced that quinolones (especially CIP) and macrolides (especially
CLA and AZI) are the most heavily used antimicrobials in all countries.
It is not surprising then that ciproﬂoxacin has been documented to be
present at high concentrations in sediment (Kristiansson et al., 2011)
and surface water (Mutiyar and Mittal, 2014) samples from India. In-
terestingly, other classes of antibiotics were detected at much lower
concentrations; the highest sulfonamide levels were detected in United
States WWTP 2 inﬂuent (1941 ng/L for sulfamethoxazole) and the
highest tetracycline levels detected was in India WWTP 2 (241 ng/L for
tetracycline).
When it comes to the eﬄuent, clarithromycin was the highest de-
tected antimicrobial (5178 ng/L in India WWTP 2), followed by sulfa-
methoxazole (1301 ng/L in Philippines WWTP 2), as shown in Table S2.
Notably, in samples originating from India WWTP 2, clarithromycin
and the macrolide-metabolite anhydro-erythromycin were found in the
μg/L concentrations in the upstream sample (Table S3), indicating
sources other than WWTP eﬄuents. Eﬄuents samples and surface
water samples from Sweden, Switzerland, and the United States had
generally very low in antimicrobial concentrations, and mostly below
the detection limits. Some of the factors that may contribute in the high
antimicrobial concentrations found in the environment include easy
access to antimicrobials without prescription and the lack of access to
toilets and sanitation facilities (Laxminarayan and Chaudhury, 2016).
The macrolides remain in the μg/L level in the downstream sample.
Ciproﬂoxacin and norﬂoxacin were also detected in the upstream
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Fig. 2. The amounts of antimicrobials found in each sample in the inﬂuent (A), eﬄuent (B), upstream (C), and downstream (D), are presented as total analyte loading
in ng/L. Higher levels can be observed in the inﬂuent compared to the eﬄuent samples. The inﬂuent samples from Hong Kong showed the highest antimicrobial
loading among all countries studied (CHE – Switzerland, HKG - Hong Kong, IND - India, PHL – Philippines, SWE – Sweden, USA – United States of America). Two
wastewater treatment plants were sampled per country and are labeled 1 and 2.
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sample from India 2 at 635 ng/L and 233 ng/L, respectively (Table S3).
A similar study, though with a more limited number of analytes,
showed similar trends in Indian environmental samples (Fick et al.,
2009).
Antidepressants, and other pharmaceuticals such as acetaminophen,
caﬀeine, carbamazepine, diclofenac, iopamidol, and trimethoprim,
were also analyzed in the samples because they may have the capability
of exerting selection pressures on bacteria. A detailed summary of the
concentrations at which these non-antimicrobial analytes were found is
presented in Table S4 and S5. The most commonly detected PPCP was
caﬀeine, which was present in 40 out of 41 samples, while diclofenac
had the highest measured concentration at 108,000 ng/L (Table S5) in a
sample downstream of a Swiss WWTP. For the antidepressants, the most
frequently detected compound was venlafaxine, which was found in 24
out of 41 samples. The antidepressant norﬂuoxetine, on the other hand,
is the compound detected with the highest concentration, of 984 ng/L
in the United States wastewater inﬂuent sample (Table S4). As a result
of the collective interplay among the physical, chemical, microbial and
genetic components of the various environments, diﬀerences in the
types and concentrations of antimicrobial and other compounds may be
associated with corresponding ARG proﬁles characteristic of each en-
vironment. Antidepressants were detected at higher concentrations in
Sweden, Switzerland, and the United States, which was expected since
these countries are among the highest consumers of antidepressants.
This reﬂects the fact that the United States is the top consumer of an-
tidepressants in the world, where 11% of the people above 12 years old
are prescribed to take these drugs (Pratt et al., 2017).
Certain challenges were encountered during surface water collec-
tion. Downstream sample collection was not possible in Hong Kong, as
the WWTP eﬄuent is discharged to the ocean where diﬀerentiating an
impacted and unimpacted site was not feasible, and sample collection
was dangerous. For samples coming from the Philippines, WWTP 1 was
inside a building receiving wastewater from both residential and
commercial sources, while the downstream sample from WWTP 2 was
in an unsafe location thus preventing the collection of the sample. For
the samples successfully collected, similar general trends in con-
taminant concentrations were observed such that they are higher in
wastewater than surface water samples. Though it was diﬃcult to dis-
cern conclusions regarding the diﬀerences in contaminant levels when
comparing upstream and downstream samples, the relatively higher
concentrations found in downstream samples demonstrated that
WWTPs are important point sources of antimicrobials and PPCPs in
many aquatic systems. One should not mistakenly attribute that the
diﬀerence in contaminant loading between these two wastewater
samples is due to removal, but it must be kept in mind that these
samples may be from diﬀerent batches of received wastewater. It is
emphasized here that the goal of the present study was not to assess
removal rates from the diﬀerent WWTPs, but rather to develop a robust
method that can be used for the global monitoring of antimicrobials and
PPCPs in WWTP eﬄuents and receiving waters from diﬀerent countries.
The results presented in this paper demonstrate the applicability of the
developed sample preparation protocols and analytical method that can
be adopted for international collaborative studies. For studies that aim
to assess WWTP removal eﬃciencies of antimicrobials or other PPCPs,
it is strongly recommended to collect composite samples in order to be
able to draw out accurate conclusions regarding the treatment eﬃ-
ciencies. It is also important to collect water samples in various sam-
pling points in the receiving waters and record the surface water ﬂow
rates and volumes to better estimate the predicted environmental
concentrations of antimicrobials and PPCPs.
In conclusion, this paper provides a cost-eﬀective and easy to im-
plement sample preparation and analytical approaches for 8 classes of
antimicrobials and other pharmaceuticals that can be used for global
monitoring in wastewater and receiving waters. Because many re-
searchers from upper middle and high income countries are partnering
with LMIC to monitor occurrence of antibiotics and PPCPs globally, it
was important to investigate critical steps in the sample preparation,
shipping, and analysis to determine the eﬀect of temperature and length
of storage on the stability of target analytes during international ship-
ment. Here, we demonstrated the robustness of the chromatographic
method for diﬀerent types of sample matrices ranging from inﬂuent and
eﬄuent wastewater, to surface waters collected from upstream and
downstream of the wastewater treatment plants. In addition, the im-
portance of applying a deﬁned tolerance for the ion ratio (Q/q) opti-
mized for wastewater and surface water to minimize false negative and
false positive detection, was demonstrated. This tolerance range was set
to be the mean ion ratio of the standard at various concentrations±
40% for the inﬂuent, and± 30% for the eﬄuent, upstream, and
downstream samples. For tetracyclines and quinolones, however, the
tolerance range was 80%. This study successfully developed a general
method for the cost-eﬀective analysis of antibiotics and PPCPs from
LMIC environments, while maintaining sample integrity and producing
high quality data.
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